Linda McDonough

Linda McDonough is a veteran hedge fund analyst who loves to break down company financial statements and identify market inefficiencies to uncover big opportunities.  She believes in a boots-on-the-ground approach that includes surveying customers, interviewing company executives, or doing whatever it takes to see what others don't.

She's now brought her experience as a hedge fund analyst to subscribers of her Profit Catalyst Alert service. Her system identifies small- and mid-cap stocks that are about to move due to catalytic events that few others can identify...until it's too late. These events often times result in massive gains for her followers.

Analyst Articles

Acuity BrandsThree of Acuity Brand’s (NYSE: AYI) decorative LED luminaires won a 2016 Lighting for Tomorrow award. The prestigious competition recognizes the best decorative, energy-efficient luminaires in the market and is organized by the American Lighting Association, the Consortium for Energy Efficiency, and Underwriters Laboratories. Acuity’s unusual lighting products showcase… Read More

GMS (NYSE: GMS) is a leading distributor of wallboard and suspending ceiling  products in North America. The company just came public in May 2016 and currently trades just above its IPO price. A mid-September report that just missed analysts’ revenue estimate sent the stock down 8% giving investors the rare… Read More

Buy Patrick Industries (PATK) makes building and component products for the recreational vehicle, manufactured housing and industrial markets. Like portfolio holding Drew Industries (DW), Patrick is enjoying the secular rise in demand for RVs. Earnings are expected to grow almost 30% this year.Jump on board as baby-boomers and millennials pump up… Read More

We’re selling SolarEdge (SEDG).  Without a doubt it has been one of the most frustrating stocks I’ve worked with in my career. Solid earnings and the best balance sheet in the sector have not been enough to fight against negative industry sentiment. I… Read More

Apogee Enterprises (NSDQ: APOG) beat second quarter estimates by $.10, reporting $.77 versus estimates of $.66. Despite the beat and an increase in estimates for fiscal 2017 (ending February 2017) the stock dropped 6%. Analysts expressed concern over a 13% decline in the company’s backlog.Due to the size of some… Read More

Makeover your portfolio with Cynosure. The company develops non-invasive and minimally invasive aesthetic treatments. Its launch of the SculpSure product (non-invasive laser treatment for fat removal) last September is boosting profits. SculpSure’s  rave reviews and high patient satisfaction is making it popular with doctors.Cynosure’s has sold hyperthermic laser treatments for over 25… Read More